Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TMEM45A |
| Upstream (Parents) |
|---|
| (<<) NNMT → TMEM45A |
| (<<) ST3GAL6 → TMEM45A |
| (<<) FERMT2 → TMEM45A |
| Downstream (Children) |
|---|
| TMEM45A → TPST1 (>>) |
| TMEM45A → OSBPL1A (>>) |
| TMEM45A → GABARAPL1 (>>) |
| TMEM45A → WNT8B (>>) |
| TMEM45A → TMEM212 (>>) |
| TMEM45A → TCL6///TCL1B (>>) |
| TMEM45A → CTRC (>>) |
| TMEM45A → CCHCR1 (>>) |
| TMEM45A → GSTT2 (>>) |
| TMEM45A → ST3GAL6 (>>) |
| TMEM45A → BAALC (>>) |
| TMEM45A → RET (>>) |
| TMEM45A → LHB (>>) |
| TMEM45A → FERMT2 (>>) |
| TMEM45A → SLCO2B1 (>>) |
